2016 – Precision Medicine: REGISTER NOW

Johns Hopkins Institute for NanoBioTechnology celebrates its tenth anniversary at their annual symposium with the theme of Precision Medicine. Registration is now open for attendees and poster registration.

2000px-High_accuracy_Low_precision.svgThe symposium will take place at Owens Auditorium (located between CRB I and CRB II at the Johns Hopkins School of Medicine on Friday, April 29. Talks begin at 9 a.m. and conclude at 12:30. A poster session in the auditorium lobby and corridor will occur from 1:30 to 3:30 p.m. Prizes will be offered for the top poster presenters, and the first 60 posters registrants will be invited to attend a special luncheon at 12:30.


To register to attend or to register a poster title for the symposium, click here. All disciplines and departments are invited to participate. The symposium is free and open to the Johns Hopkins University community and select other academic institutions. A registration fee may apply to other attendees. 

NOTE: Posters should be 3′ by 4′ or no larger than 4′ by 4′ in size and should be in place by 1:15 p.m.. Poster presenters will find out where their poster is to be displayed on the day of the symposium.

According to the National Institutes of Health:

Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. While some advances in precision medicine have been made, the practice is not currently in use for most diseases. That’s why on January 20, 2015, President Obama announced the Precision Medicine Initiative® (PMI) in his State of the Union address. Through advances in research, technology and policies that empower patients, the PMI will enable a new era of medicine in which researchers, providers and patients work together to develop individualized care.


The AGENDA for the day is as follows:

Help INBT celebrate 10 years of fostering and facilitating collaborative multidisciplinary research across all divisions and departments of the University.

Launched in 2006, INBT focuses its efforts in research on the basic biological sciences, the clinical sciences, and public health. In the basic biological sciences, INBT supports research exploiting nanoscience to advance our understanding of cellular and molecular dynamics at the molecular level. In the clinical sciences, INBT supports research to develop novel methods for diagnostics and therapeutics. In public health, INBT supports research to understand the potential impact of nanoscience and nanotechnology on health and the environment, as well as on using nanoscience to solve environmental problems.

Direct media inquiries to Mary Spiro at


2015 – Neuro X

2014 – Stem Cell Science and Engineering: State of the Art

Faculty experts gathered Friday, May 2, at the Owens Auditorium at the Johns Hopkins School of Medicine to discuss the clinical, the engineering and the commercial aspects of stem cells. Speakers included Linzhao Cheng, PhD, Oncology/Stem Cell program, JHMI; Linda M. S. Resar, MD, Oncology/ICE JHMI; Hai-Quan Mao, PhD, Materials Science and Engineering, JHU; Warren Grayson, PhD, Biomedical Engineering, JHU; Mark Powers, PhD, R&D Thermo Fisher Scientific; and Gou-li Ming, PhD, Neurology/ICE JHMI.

2013 – Translating the Promise of Nanoscience from Laboratory to Development

Held at Shriver Auditorium Friday, May 17 on the Homewood campus from 8 a.m. – 3 p.m. Speakers included industry and faculty experts who are succuessfully translating their science and engineering innovations into technologies that can help people and solve problems in healthcare and medicine. An afternoon poster session featured the nano-bio related research from laboratories across the University system, including work from the Johns Hopkins School of Medicine, School of Public Health, Krieger School of Arts and Sciences, Whiting School of Engineering and the Applied Physics Laboratory.

2012 – Cancer: The Big Picture

Exploring the diagnosis and treatment of cancer from a variety of novel approaches using epidemiology, physical sciences, genetics, and cell biology. The sixth annual symposium of Johns Hopkins Institute for NanoBioTechnology (INBT) was held on May 4, 2012 at the university’s Medical Campus.

2011 – Nanotechnology for Cancer Medicine

Nanotechnology for Cancer Medicine formed the focus of the fifth annual symposium of Johns Hopkins Institute for NanoBioTechnology (INBT). The even was held on May 12-13, 2011 at the university’s Homewood campus.

2010 – Environmental and Health Impacts of Engineered Nanomaterials

Johns Hopkins Institute for NanoBioTechnology 4th Annual Symposium was held on Thursday, April 29th, 2010 at the Johns Hopkins Bloomberg School of Public Health.

2009 -Nanoscience for Neuroscience and Neurosurgery

Nanoscience for Neuroscience and Neurosurgery, INBT’s 3rd annual symposium was held Monday, May 18, 2009  from 9 a.m. until noon in Mountcastle Auditorium of the PreClinical Teaching Building. A poster session was held in Turner Concourse on the Johns Hopkins medical campus. Speakers from the Johns Hopkins School of Medicine included Ted Dawson, Abramson Professor of Neurodegenerative Diseases; John W. Griffin, Johns Hopkins University Distinguished Service Professor of Neurology, Neuroscience and Pathology and director of the Brain Science Institute; Michael T. McMahon, assistant professor of Radiology, MR Division; Alessandro Olivi, professor of Neurosurgery and Oncology and chair of Neurosurgery at Johns Hopkins Bayview Medical Center; and Jeffrey Rothstein, professor of Neurology and director of the Robert Packard Center for ALS Research.

2008 – Nanotechnology for Cancer

All facets of research relating to the emerging discipline of nanobiotechnology were explored at the second annual Johns Hopkins NanoBio Symposium, May 1 -2, 2008. “Nanotechnology for Cancer“  was the focus of Thursday’s workshop, co-hosted by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. This workshop featured short presentations and engaging discussions with several Johns Hopkins faculty experts working in areas relating to nanobiotechnology. Invited speakers included Donald E. Ingber, M.D., Ph.D., professor or vascular biology from the Harvard Medical School; Andrew D. Maynard, Ph.D., chief science advisor for the Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars; Paras N. Prasad, Ph.D., director of the Institute for Lasers, Photonics, and Biophotonics at the University at Buffalo; Jeffery A. Schloss, Ph.D., from the National Human Genome Research Institute; and Jennifer L. West, Ph.D., professor of bioengineering at Rice University.


The first annual symposium for nanobiotechnology at Johns Hopkins Universtity washeld on Friday, April 27, 2007 on the Homewood campus. Speakers included Michael P.Sheetz, Prof., Biological Sciences, Columbia University; David J. Mooney, Prof., Bioengineering, Harvard University; Günter Oberdörster, Prof., Environmental Medicine, University of Rochester; Dennis Discher, Prof., Chemical and Biomolecular Engineering, University of Pennsylvania; Gang Bao, Prof, Biomedical Engineering, Georgia Institute of Technology; Wendy Sanhai, Senior Scientific Advisor, FDA; Greg Downing, Director, Office of Technology and Industrial Relationships, NCI; and Piotr Grodzinski, Director, Nanotechnology Alliance for Cancer, NCI.